WILHELMUS CM GROENHUYSEN - 02 Mar 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Operating Officer
Signature: Steven Robbins, as attorney in fact for Groenhuysen, Wilhelmus CM
Issuer symbol: NVCR
Transactions as of: 02 Mar 2023
Net transactions value: -$91,312
Form type: 4
Filing time: 06 Mar 2023, 15:40:52 UTC
Previous filing: 02 Mar 2023
Next filing: 07 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Sale	$91,312	-1,213	-0.66%	$75.28	183,402	02 Mar 2023	Direct	F1
transaction	NVCR	Ordinary Shares	Award	$0	+48,050	+26%	$0.000000	231,452	03 Mar 2023	Direct	F2
transaction	NVCR	Ordinary Shares	Award	$0	+3,936	+1.7%	$0.000000	235,388	03 Mar 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	Represents vesting of performance-based restricted stock units.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Represents vesting of performance-based restricted stock units.